alprazolam has been researched along with Phobic Disorders in 71 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examines clinical predictors of outcome for patients with panic disorder and depression in a 16 week, placebo-controlled trial of alprazolam and imipramine (n = 126)." | 9.07 | Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. ( Deltito, JA; Keller, MB; Leon, A; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, MK, 1994) |
| "A cross-national randomised trial of alprazolam for chronic panic disorder with agoraphobia was run." | 9.07 | Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. ( Başoğlu, M; Kirby, M; Kuch, K; Lelliott, PT; Marks, IM; McNamee, G; Noshirvani, H; O'Sullivan, G; Sengun, S; Swinson, RP, 1993) |
| "Fifty-five patients completed a 5-week double-blind study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks." | 9.06 | Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. ( Brown, R; Cabe, D; Crocker, B; Leonard, M; McDowell, D; McManus, M; Munjack, DJ; Palmer, R; Usigli, R; Zulueta, A, 1989) |
| "In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 9.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
| " A decrease in therapeutic effects of alprazolam after an initial good response is described in three patients suffering from panic disorder with agoraphobia." | 7.67 | Fading of therapeutic effects of alprazolam in agoraphobia. Case reports. ( Fava, GA, 1988) |
| "Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)." | 7.67 | Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986) |
| "Alprazolam resulted in lower anxiety and pain ratings during pain stimulation, supporting the idea that (presumably pain-related) anxiety may increase the experience of pain." | 6.69 | No interactive effects of naltrexone and benzodiazepines on pain during phobic fear. ( Arntz, A; Janssen, SA, 1999) |
| "Panic disorder is a chronic illness with only some degree of spontaneous recovery." | 6.67 | Discontinuation reactions to alprazolam in panic disorder. ( Pecknold, JC, 1993) |
| " By the response of the patients to alprazolam (anxiolytic) and fluoketin (antidepressant) given by a special scheme, 3 types of comorbidity of obsessional-phobic and affective disturbances were recognized: 1) prevalent depression, 2) combination of dysthymia with marked obsessional-phobic disorders, 3) overcoming of obsessional-phobic and affective disorders." | 5.07 | [The psychopharmacotherapy of anxious-depressive states (the interrelationship of the structure of the comorbidity to the choice of drug therapy)]. ( Andriushchenko, AV; Koliutskaia, EV; Morkovkina, IV; Smulevich, AB; Tkhostov, ASh, 1994) |
| "This study examines clinical predictors of outcome for patients with panic disorder and depression in a 16 week, placebo-controlled trial of alprazolam and imipramine (n = 126)." | 5.07 | Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. ( Deltito, JA; Keller, MB; Leon, A; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, MK, 1994) |
| "A cross-national randomised trial of alprazolam for chronic panic disorder with agoraphobia was run." | 5.07 | Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. ( Başoğlu, M; Kirby, M; Kuch, K; Lelliott, PT; Marks, IM; McNamee, G; Noshirvani, H; O'Sullivan, G; Sengun, S; Swinson, RP, 1993) |
| "Fifty-five patients completed a 5-week double-blind study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks." | 5.06 | Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. ( Brown, R; Cabe, D; Crocker, B; Leonard, M; McDowell, D; McManus, M; Munjack, DJ; Palmer, R; Usigli, R; Zulueta, A, 1989) |
| "In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 5.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
| " A double blind study of alprazolam and placebo in 118 patients with agoraphobia and panic is presented." | 5.06 | Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. ( Kuch, K; Pecknold, JC; Swinson, RP, 1987) |
| "Thirty-two patients with chronic debilitating agoraphobia and panic attacks participated in a comparative study of the triazolobenzodiazepine alprazolam and the anti-inflammatory agent ibuprofen." | 5.05 | Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. ( Coleman, JH; Greenblatt, DJ; Jones, KJ; Levine, PH; Orsulak, PJ; Peterson, M; Schildkraut, JJ; Sheehan, DV; Uzogara, E; Watkins, D, 1984) |
| "Patients who met DSM-III criteria for agoraphobia with panic attacks underwent dexamethasone suppression tests (DSTs) before, during, and after treatment with alprazolam or placebo." | 5.05 | Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks. ( Chaudhry, D; Clancy, J; Coryell, W; Crowe, R; Noyes, R, 1985) |
| " For panic disorder and agoraphobia with panic, the tricyclic antidepressants, the monoamine oxidase inhibitors, and the atypical benzodiazepine alprazolam have proved effective." | 4.77 | Pharmacotherapeutic considerations in anxiety disorders. ( Hollister, LE, 1986) |
| "Four patients with panic disorder whose panic attacks responded to benzodiazepine treatment but who suffered persistent anxiety improved after addition of buspirone." | 3.67 | Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. ( Gastfriend, DR; Rosenbaum, JF, 1989) |
| "The anxiolytic triazolobenzodiazepine alprazolam was administered to six male patients, aged 26 to 46 years, with panic disorder or agoraphobia (with panic attacks) to assess clinical effects and steady-state pharmacokinetics following multiple dosing at three levels: 3." | 3.67 | Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. ( Barnhill, JG; Boxenbaum, HG; Ciraulo, DA; Greenblatt, DJ; Smith, RB, 1986) |
| " A decrease in therapeutic effects of alprazolam after an initial good response is described in three patients suffering from panic disorder with agoraphobia." | 3.67 | Fading of therapeutic effects of alprazolam in agoraphobia. Case reports. ( Fava, GA, 1988) |
| "Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)." | 3.67 | Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986) |
| "Alprazolam was given at a dosage of 0." | 2.71 | Use of clomipramine, alprazolam, and behavior modification for treatment of storm phobia in dogs. ( Crowell-Davis, SL; Curtis, TM; Parthasarathy, V; Seibert, LM; Sung, W, 2003) |
| "Alprazolam resulted in lower anxiety and pain ratings during pain stimulation, supporting the idea that (presumably pain-related) anxiety may increase the experience of pain." | 2.69 | No interactive effects of naltrexone and benzodiazepines on pain during phobic fear. ( Arntz, A; Janssen, SA, 1999) |
| "Panic disorder is a chronic illness with only some degree of spontaneous recovery." | 2.67 | Discontinuation reactions to alprazolam in panic disorder. ( Pecknold, JC, 1993) |
| "Alprazolam was effective in reducing panic and depressive symptomatology in both depressed and nondepressed subjects with panic disorder." | 2.66 | Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. ( Burrows, GD; DuPont, RL; Lesser, IM; Lydiard, RB; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
| " Finally, the authors discuss general issues concerning the relapse of patients upon drug discontinuation, the long-term use of benzodiazepines, and other important issues concerning the use of these agents for the treatment of social phobia." | 2.39 | Treatment of social phobia with benzodiazepines. ( Davidson, JR; Potts, NL; Tupler, LA, 1994) |
| "Before treatment, IBQ hypochondriasis scores were similar to those of a group of hypochondriacal psychiatric patients." | 1.27 | Reduction in hypochondriasis with treatment of panic disorder. ( Clancy, J; Noyes, R; O'Gorman, TW; Reich, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (57.75) | 18.7374 |
| 1990's | 20 (28.17) | 18.2507 |
| 2000's | 6 (8.45) | 29.6817 |
| 2010's | 4 (5.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orlando, JM | 1 |
| Gómez-Arnau, J | 1 |
| Martín-Larrégola, M | 1 |
| Rabito-Alcón, MF | 1 |
| Dolengevich-Segal, H | 1 |
| Gutiérrez-Velasco, L | 1 |
| Correas-Lauffer, J | 1 |
| Stepita, ME | 1 |
| Bain, MJ | 1 |
| Ries, R | 1 |
| Wolitzky-Taylor, KB | 1 |
| Operskalski, JT | 1 |
| Craske, MG | 1 |
| Roy-Byrne, P | 1 |
| Crowell-Davis, SL | 1 |
| Seibert, LM | 1 |
| Sung, W | 1 |
| Parthasarathy, V | 1 |
| Curtis, TM | 1 |
| Biermann, T | 1 |
| Bleich, S | 1 |
| Kornhuber, J | 1 |
| Hillemacher, T | 1 |
| Barthelmé, B | 1 |
| Poirot, Y | 1 |
| Sheehan, DV | 5 |
| Coleman, JH | 1 |
| Greenblatt, DJ | 2 |
| Jones, KJ | 2 |
| Levine, PH | 1 |
| Orsulak, PJ | 1 |
| Peterson, M | 1 |
| Schildkraut, JJ | 1 |
| Uzogara, E | 1 |
| Watkins, D | 1 |
| Mark, SL | 1 |
| Ballenger, JC | 4 |
| Van Winter, JT | 1 |
| Stickler, GB | 1 |
| Campbell, M | 1 |
| Cueva, JE | 1 |
| Smulevich, AB | 1 |
| Andriushchenko, AV | 1 |
| Morkovkina, IV | 1 |
| Tkhostov, ASh | 1 |
| Koliutskaia, EV | 1 |
| Katz, RC | 1 |
| Wilson, L | 1 |
| Frazer, N | 1 |
| Pollack, MH | 6 |
| Otto, MW | 2 |
| Sachs, GS | 3 |
| Leon, A | 1 |
| Shear, MK | 1 |
| Deltito, JA | 1 |
| Keller, MB | 1 |
| Rosenbaum, JF | 6 |
| Davidson, JR | 1 |
| Tupler, LA | 1 |
| Potts, NL | 1 |
| Marks, IM | 1 |
| Swinson, RP | 5 |
| Başoğlu, M | 1 |
| Kuch, K | 2 |
| Noshirvani, H | 1 |
| O'Sullivan, G | 1 |
| Lelliott, PT | 1 |
| Kirby, M | 1 |
| McNamee, G | 1 |
| Sengun, S | 1 |
| Pecknold, JC | 5 |
| Wilhelm, FH | 2 |
| Roth, WT | 2 |
| Matthews, J | 1 |
| Scott, EL | 1 |
| Janssen, SA | 1 |
| Arntz, A | 1 |
| de Jong, PJ | 1 |
| Merckelbach, H | 1 |
| Jefferson, JW | 1 |
| García-Campayo, JJ | 1 |
| Febrel Bordeje, M | 1 |
| Campos Ródenas, R | 1 |
| García Mur, MC | 1 |
| Covelli, V | 1 |
| Munno, I | 1 |
| Decandia, P | 1 |
| Altamura, M | 1 |
| Cannuscio, B | 1 |
| Maffione, AB | 1 |
| Jirillo, E | 1 |
| Klein, DS | 1 |
| Gelernter, CS | 1 |
| Uhde, TW | 2 |
| Cimbolic, P | 1 |
| Arnkoff, DB | 1 |
| Vittone, BJ | 1 |
| Tancer, ME | 2 |
| Bartko, JJ | 1 |
| Argyle, N | 1 |
| Solyom, C | 1 |
| Solyom, L | 1 |
| Sargent, M | 1 |
| Bernstein, GA | 1 |
| Garfinkel, BD | 1 |
| Borchardt, CM | 1 |
| O'Neil, C | 1 |
| Asher, R | 1 |
| Meltzer-Brody, S | 1 |
| Lopez, AL | 1 |
| Kathol, RG | 1 |
| Noyes, R | 7 |
| Fava, M | 1 |
| MacLaughlin, RA | 1 |
| Tesar, GE | 3 |
| Cohen, LS | 1 |
| Hirsch, M | 1 |
| Gastfriend, DR | 1 |
| Pyke, RE | 1 |
| Greenberg, HS | 1 |
| Munjack, DJ | 1 |
| Crocker, B | 1 |
| Cabe, D | 1 |
| Brown, R | 1 |
| Usigli, R | 1 |
| Zulueta, A | 1 |
| McManus, M | 1 |
| McDowell, D | 1 |
| Palmer, R | 1 |
| Leonard, M | 1 |
| Hauri, PJ | 1 |
| Friedman, M | 1 |
| Ravaris, CL | 1 |
| Carek, DJ | 1 |
| Steele, JJ | 1 |
| Cornish-McTighe, D | 1 |
| Rajadhyaksha, S | 1 |
| Hoehn-Saric, R | 1 |
| McLeod, DR | 1 |
| Coryell, W | 2 |
| Clancy, J | 2 |
| Crowe, R | 1 |
| Chaudhry, D | 1 |
| Ciraulo, DA | 1 |
| Barnhill, JG | 1 |
| Boxenbaum, HG | 1 |
| Smith, RB | 1 |
| Scrignar, CB | 1 |
| Hollister, LE | 1 |
| Greenberg, DB | 2 |
| Stern, TA | 2 |
| Weilburg, JB | 2 |
| Rizley, R | 1 |
| Kahn, RJ | 1 |
| McNair, DM | 1 |
| Frankenthaler, LM | 1 |
| Mayerhoff, D | 1 |
| Vital-Herne, J | 1 |
| Lesser, M | 1 |
| Brenner, R | 1 |
| Reich, J | 3 |
| Yates, W | 2 |
| Herman, JB | 1 |
| Fyer, AJ | 3 |
| Liebowitz, MR | 2 |
| Gorman, JM | 2 |
| Campeas, R | 1 |
| Levin, A | 1 |
| Sandberg, D | 1 |
| Fyer, M | 1 |
| Hollander, E | 1 |
| Papp, L | 1 |
| Goetz, D | 1 |
| Lesser, IM | 1 |
| Rubin, RT | 2 |
| Rifkin, A | 2 |
| Lydiard, RB | 2 |
| Burrows, GD | 2 |
| DuPont, RL | 2 |
| Laraia, MT | 1 |
| Howell, EF | 1 |
| Shea, CA | 1 |
| Fava, GA | 1 |
| Dillon, D | 1 |
| Cohen, BS | 1 |
| Klein, DF | 1 |
| Surman, OS | 1 |
| Williams, J | 1 |
| Strom, TB | 1 |
| Coleman, J | 1 |
| Spier, SA | 1 |
| Woods, SW | 1 |
| Raj, A | 1 |
| O'Gorman, TW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Role of Orexin in Human Panic Disorder[NCT02593682] | Phase 4 | 3 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for alprazolam and Phobic Disorders
| Article | Year |
|---|---|
Psychopharmacology of the anxiety disorders.
Topics: Adrenergic beta-Antagonists; Adult; Agoraphobia; Alprazolam; Antidepressive Agents, Tricyclic; Anxie | 1984 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder | 1995 |
Treatment of social phobia with benzodiazepines.
Topics: Alprazolam; Benzodiazepines; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Humans; Phob | 1994 |
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.
Topics: Adolescent; Age of Onset; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Cognitive Behavior | 2001 |
Effects of benzodiazepines on the immune system.
Topics: Alprazolam; Antibody Formation; Benzodiazepines; Diazepam; Humans; Immune System; Immunity, Cellular | 1991 |
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cheese; Diet; Drug-Related Side | 1985 |
Generalized anxiety disorder.
Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyc | 1985 |
Pharmacotherapeutic considerations in anxiety disorders.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; B | 1986 |
Agoraphobia.
Topics: Agoraphobia; Alprazolam; Behavior Therapy; Humans; Imipramine; Phobic Disorders | 1988 |
27 trials available for alprazolam and Phobic Disorders
| Article | Year |
|---|---|
Use of clomipramine, alprazolam, and behavior modification for treatment of storm phobia in dogs.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Behavior Therapy; Behavi | 2003 |
Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; | 1984 |
[The psychopharmacotherapy of anxious-depressive states (the interrelationship of the structure of the comorbidity to the choice of drug therapy)].
Topics: Adult; Alprazolam; Anxiety; Comorbidity; Depression; Double-Blind Method; Female; Fluoxetine; Humans | 1994 |
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Topics: Adult; Aged; Alprazolam; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imip | 1994 |
Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Arousal; Combined Modality Therapy; Desensitizatio | 1993 |
Discontinuation reactions to alprazolam in panic disorder.
Topics: Agoraphobia; Alprazolam; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Adminis | 1993 |
Acute and delayed effects of alprazolam on flight phobics during exposure.
Topics: Adult; Aircraft; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Case-Control Studie | 1997 |
Using minute ventilation for ambulatory estimation of additional heart rate.
Topics: Adult; Aircraft; Alprazolam; Anti-Anxiety Agents; Arousal; Cognitive Behavioral Therapy; Combined Mo | 1998 |
No interactive effects of naltrexone and benzodiazepines on pain during phobic fear.
Topics: Adolescent; Adult; Alprazolam; Anxiety; Benzodiazepines; Drug Interactions; Electroshock; Female; Hu | 1999 |
Phobia-relevant illusory correlations: the role of phobic responsivity.
Topics: Adolescent; Adult; Alprazolam; Animals; Arousal; Association Learning; Conditioning, Classical; Doub | 2000 |
Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
Topics: Adolescent; Adult; Alprazolam; Ambulatory Care; Behavior Therapy; Cognitive Behavioral Therapy; Doub | 1991 |
The structure of phobias in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; | 1991 |
Comparative studies of pharmacotherapy for school refusal.
Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double- | 1990 |
Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Benzodiazepines; Depression; Diazepam; Fear; Female; Humans; Hydroco | 1990 |
Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Clinical Trials as Topic; Clonazepam; Dehydroepiandrosterone; Double | 1989 |
Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Arousal; Benzodiazepines | 1989 |
Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Clinical Trials as Topic; Double-Blind Method; Fear; Fem | 1989 |
Sleep in patients with spontaneous panic attacks.
Topics: Adolescent; Adult; Alprazolam; Cerebral Cortex; Clinical Trials as Topic; Double-Blind Method; Elect | 1989 |
Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Dexametha | 1985 |
A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as To | 1986 |
HPA axis disturbance and treatment outcome in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Clinical Trials as Topic; Dexamethasone; Fear; Female; Humans; Hydro | 1988 |
A pilot study of treatment of social phobia with alprazolam.
Topics: Adult; Aged; Alprazolam; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Mal | 1988 |
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Do | 1988 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Ataxia; Chemical and Drug Induced Liver Injury; F | 1988 |
Immunological response to stress in agoraphobia and panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear; | 1986 |
Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Fear; Humans; Panic; P | 1987 |
Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Alprazolam; Benzodiazepines; Fear; Female; Humans; Male; Panic; Phobic Disorders | 1986 |
35 other studies available for alprazolam and Phobic Disorders
| Article | Year |
|---|---|
Animal Behavior Case of the Month.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal | 2017 |
Effectiveness of a non-sedative intervention to prevent anxious and claustrophobic reactions in magnetic resonance imaging.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Female; Humans; Magnetic Resonance Imaging; Male; Middle A | 2018 |
Animal behavior case of the month. Noise phobia, cognitive dysfunction, separation anxiety, attention-seeking behavior, and medical causes.
Topics: Aggression; Alprazolam; Animals; Behavior, Animal; Dog Diseases; Dogs; Dose-Response Relationship, D | 2013 |
Treatment of comorbid substance use and anxiety disorders: a case study.
Topics: Adult; Alcoholism; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anticonvulsants; Cognitive Beha | 2011 |
Pregabalin in benzodiazepine withdrawal.
Topics: Adult; Alprazolam; Anticonvulsants; Anxiety Disorders; gamma-Aminobutyric Acid; Humans; Hypnotics an | 2007 |
[Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Cardio | 2008 |
Agoraphobia and panic disorder: treatment with alprazolam.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Fear; Female | 1984 |
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bupropion; Depressive Disorder; Dexamethasone; Fear; | 1984 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven | 1984 |
Anxiety and its determinants in patients undergoing magnetic resonance imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Anxiety; Fear; Female; Humans; Magnetic Reso | 1994 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids | 1998 |
Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder).
Topics: Acetates; Alprazolam; Amines; Anticonvulsants; Benzodiazepines; Clinical Trials as Topic; Clonazepam | 2001 |
[Economic impact of integrating mental health in primary health care: apropos of a case].
Topics: Adult; Alprazolam; Antidepressive Agents; Anxiety Disorders; Humans; Interprofessional Relations; Ma | 1992 |
Prevention of claustrophobia induced by MR imaging: use of alprazolam.
Topics: Alprazolam; Humans; Magnetic Resonance Imaging; Phobic Disorders; Premedication | 1991 |
Panic disorder.
Topics: Alprazolam; Behavior Therapy; Fear; Health Education; Humans; Imipramine; National Health Programs; | 1990 |
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T | 1990 |
Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Buspirone; Clonazepam; Diazepam; Drug Combinations; | 1989 |
Three cases of panic disorder with agoraphobia in children.
Topics: Adolescent; Agoraphobia; Alprazolam; Child; Fear; Female; Humans; Imipramine; Male; Panic; Phobic Di | 1989 |
Avoidant personality traits in social phobic patients treated with alprazolam.
Topics: Alprazolam; Humans; Personality Disorders; Phobic Disorders; Psychotherapy | 1989 |
Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
Topics: Administration, Oral; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Dose-Res | 1986 |
Postpanic anxiety disorder: diagnosis and treatment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen | 1986 |
Fear of choking.
Topics: Adult; Airway Obstruction; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Body Weight; Fear; Feed | 1986 |
Alprazolam-induced manic reaction.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder | 1986 |
Alprazolam treatment of avoidant personality traits in social phobic patients.
Topics: Adult; Alprazolam; Anxiety Disorders; Female; Humans; Male; Panic; Personality Disorders; Phobic Dis | 1989 |
Clonazepam in the treatment of panic disorder and agoraphobia.
Topics: Adult; Aged; Agoraphobia; Alprazolam; Carbon Dioxide; Clonazepam; Fear; Female; Humans; Male; Middle | 1987 |
Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study.
Topics: Adult; Alprazolam; Clonidine; Female; Humans; Male; Phobic Disorders; Prospective Studies; Psychiatr | 1988 |
Alprazolam in the treatment of social phobia.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Female; Humans; Male; Middle Aged; Panic; Phobic | 1988 |
The fear of choking: three successfully treated cases.
Topics: Adult; Airway Obstruction; Alprazolam; Female; Humans; Male; Phobic Disorders | 1988 |
Sexual dysfunction related to alprazolam treatment of social phobia.
Topics: Adult; Alprazolam; Ejaculation; Female; Humans; Male; Middle Aged; Orgasm; Phenelzine; Phobic Disord | 1988 |
Fading of therapeutic effects of alprazolam in agoraphobia. Case reports.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Dose-Response Relationship, Drug; Female; Follow-Up Stud | 1988 |
Antipanic drug effects during lactate infusion in lactate-refractory panic patients.
Topics: Adult; Agoraphobia; Alprazolam; Clonidine; Desipramine; Fear; Female; Fluoxetine; Humans; Imipramine | 1987 |
Agoraphobia.
Topics: Agoraphobia; Alprazolam; Anxiety, Separation; Behavior Therapy; Combined Modality Therapy; Humans; I | 1987 |
Treatment of panic disorder and agoraphobia with clonazepam.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepino | 1986 |
Panic anxiety: diagnosis, etiology, and treatment.
Topics: Alprazolam; Anxiety; Behavior Therapy; Brain; Fear; Female; Humans; Lactates; Male; Monoamine Oxidas | 1986 |
Reduction in hypochondriasis with treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Fear; Humans; Hypochondriasis; Panic; Phobic Disorders; Sick Role | 1986 |